Verizon Business has been selected to manage Astellas Pharma Inc.'s global network infrastructure. The network transformation will enable Astellas to harness advanced technologies to help reduce drug development timelines, healthcare costs and drive new revenue opportunities for the Japanese pharmaceutical multinational.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.7 USD | +2.85% | -0.18% | +5.31% |
Apr. 23 | Wolfe Research Adjusts Verizon Communications Price Target to $47 From $48 | MT |
Apr. 23 | Scotiabank Adjusts Verizon Communications Price Target to $45.50 From $46 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.31% | 167B | |
+8.80% | 195B | |
0.00% | 115B | |
-0.99% | 93.11B | |
+16.84% | 73.13B | |
+0.70% | 57.69B | |
-4.83% | 51.11B | |
-13.44% | 40.25B | |
-31.47% | 38.45B | |
+7.14% | 31.39B |
- Stock Market
- Equities
- VZ Stock
- News Verizon Communications
- Astellas Pharma Selects Verizon Business to Transform Global Network Infrastructure